<DOC>
	<DOCNO>NCT00967564</DOCNO>
	<brief_summary>The purpose study evaluate correlation quality life ( QoL ) hemoglobin patient affect myelodysplastic syndrome compare MDS ( MyeloDisplastic Syndrome ) patient 's self-assessed QoL accord physician 's evaluation</brief_summary>
	<brief_title>Survey QUality Life In myeloDisplasia ( SQUID )</brief_title>
	<detailed_description>In low-risk Myelodysplastic Syndrome ( MDS ) , anemia major clinical problem often represent principal cause symptom negatively influence quality life ( QoL ) . Moreover anemia associate increased cardiac disease , old patient , may aggravate pre-existing condition congestive heart failure . Patients MDS often require red blood cell transfusion deteriorate patient ' perception well-being . This 18-month prospective observational investigation Quality Life Myelodysplastic patient aim evaluate correlation hemoglobin ( Hb ) value QoL compare MDS patient 's self-assessed QoL per physician 's assessment . One hundred fifty consecutive MDS patient diagnosis least one cytopenia - low level hemoglobin low level neutrophil ( type white blood cell fight infection ) low level platelet ( irregularly shape cell find blood help prevent bleeding ) - include evaluation . Demographic disease-specific data collect QoL evaluate specific questionnaire name QoL-E complete patient respective physician . Study visit perform monthly week 12 ; subsequent visit perform 6 , 12 18 month . No Serious Adverse Event collect study , adverse reaction Janssen-Cilag drug report . This information may important optimize treatment accord patient ' preference expectation , detect functional complication , well improve communication patient caregiver . Observational study - No study drug administer .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<criteria>Primary secondary MDS At least one cytopenia accord International Prognostic Score System ( IPSS ) criterion ( Hb &lt; 10 g/dL Absolute neutrophils count ( type white cell fight infection ) &lt; 1.800/µL platelet ( irregularly shape cell find blood help prevent bleed ) &lt; 100.000/µL ) Willing able , base investigator 's judgment , fill QoL questionnaire Refractory anemia excess blast ( tumor cell locate marrow &gt; 20 % ) Eastern Cooperative Oncology Group Performance Status ( ECOG PS ) &gt; 3 History cerebrovascular disease cognitive outcome Psychiatric disease senile vascular dementia Positive anamnesis another clinically active tumor treatment stop since less 5 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Myelodysplastic Syndrome</keyword>
	<keyword>Quality Life</keyword>
	<keyword>Anemia</keyword>
	<keyword>Epoetin alfa</keyword>
	<keyword>Eprex</keyword>
</DOC>